EP3347002
Meðhöndlun á Alzheimers-sjúkdómi í ákveðnu sjúklingaþýði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.9.2016EP published:
7.6.2023EP application number:
16845181.3
EP translation filed:
17.7.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
8.9.2036Expiry date:
8.9.2026Next due date:
30.9.2026
Title in English:
TREATMENT OF ALZHEIMER'S DISEASE IN A PARTICULAR PATIENT POPULATIONLanguage of the patent:
English
Timeline
Today
9.9.2016EP application
7.6.2023EP Publication
17.7.2023Translation submitted
15.8.2023Registration published
8.9.2026Expires
Owner
Name:
Alzheon, Inc.Address:
111 Speen Street Suite 306, Framingham, MA 01701, US
Inventor
Name:
ABUSHAKRA, SusanAddress:
Framingham, Massachusetts 01701, US
Name:
POWER, AidanAddress:
Framingham, Massachusetts 01701, US
Name:
TOLAR, MartinAddress:
Framingham, Massachusetts 01701, US
Name:
HEY, JohnAddress:
Framingham, Massachusetts 01701, US
Name:
YU, JeremyAddress:
Framingham, Massachusetts 01701, US
Name:
KOCIS, PetrAddress:
Framingham, Massachusetts 01701, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562216404 PDate:
10.9.2015Country:
US
Number:
201662290287 PDate:
2.2.2016Country:
US
Number:
201662302027 PDate:
1.3.2016Country:
US
Number:
201662365809 PDate:
22.7.2016Country:
US
Classification
Categories:
A61K 31/185, A61K 31/205, C07C 309/02, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 12.9.2023
Expires: 8.9.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 10.9.2024
Expires: 8.9.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 11.9.2025
Expires: 8.9.2026
Payer: G.H. Sigurgeirsson ehf.